Patrick van Berkel
Chief Scientific Officer ADC Therapeutics
Seminars
Wednesday 5th November 2025
Exploring a Rational Design Approach to Novel Exatecan-Based Payloads for Application in Dual Conjugate ADCs
12:00 pm
- Exploring the prospect of dual conjugate ADCs versus classic ADC design
- Assessing generation of novel exatecan based linker-drugs to maximize the design space for dual conjugate ADCs
- Examining selection of targets and payload combinations for dual conjugate ADCsÂ
